Yazıcı Ramiz, Mutlu Hüseyin, Sert Ekrem Taha, Kokulu Kamil, Turan Ömer Faruk
Department of Emergency Medicine, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Türkiye.
Department of Emergency Medicine, Aksaray University Medical School, Aksaray, Türkiye.
Emerg Med Int. 2024 Nov 11;2024:9640278. doi: 10.1155/2024/9640278. eCollection 2024.
Anaphylaxis is a serious allergic reaction that has a rapid onset and can result in death. Identifying the factors that trigger anaphylaxis and increase its severity is important for preventing refractory anaphylaxis (RA). In this study, we aimed to determine the factors associated with an increased risk of developing RA. Preventive measures to reduce the frequency and intensity of anaphylactic events are essential to provide the best care for allergic patients. Aggravating factors can trigger or increase the severity of anaphylaxis and therefore need to be recognized and avoided. We retrospectively analyzed the data of 1378 patients over the age of 18 who were diagnosed with anaphylaxis in our clinic between January 1, 2020, and December 31, 2024. We divided the patients into two groups: anaphylaxis and RA. We evaluated the patients' clinical characteristics in the ED, demographic information, and elicitors that caused anaphylaxis. Of the 1384 anaphylaxis patients included in the study, 46 (3.3%) were diagnosed as RA. We determined that having a history of anaphylaxis is the most important determinant of the increased risk of RA. Having a history of anaphylaxis (OR: 2.87, 95% CI: 1.71-5.72), beta-blockers/ACEI use (OR: 2.47, 95% CI: 1.71-5.42), IV contrast agent (OR: 2.33, 95% CI: 1.64-5.39), and low blood pressure or related symptoms (OR: 2.34, 95% CI: 1.67-5.43) were more frequently associated with severe reactions. We found that having low blood pressure or related symptoms, a known history of anaphylaxis, beta-blockers/ACEI, and IV contrast agent are risk factors for RA. To prevent mortality and morbidity in patients with this risk factor, early interventions such as rapidly repeating epinephrine doses and rapid fluid resuscitation should not be avoided.
过敏反应是一种起病迅速且可能导致死亡的严重过敏反应。识别引发过敏反应并加重其严重程度的因素对于预防难治性过敏反应(RA)至关重要。在本研究中,我们旨在确定与RA发生风险增加相关的因素。采取预防措施以减少过敏事件的频率和严重程度对于为过敏患者提供最佳护理至关重要。加重因素可触发或增加过敏反应的严重程度,因此需要识别并避免。我们回顾性分析了2020年1月1日至2024年12月31日期间在我们诊所被诊断为过敏反应的1378名18岁以上患者的数据。我们将患者分为两组:过敏反应组和RA组。我们评估了患者在急诊科的临床特征、人口统计学信息以及引起过敏反应的诱发因素。在纳入研究的1384名过敏反应患者中,46名(3.3%)被诊断为RA。我们确定有过敏反应病史是RA发生风险增加的最重要决定因素。有过敏反应病史(比值比:2.87,95%置信区间:1.71 - 5.72)、使用β受体阻滞剂/血管紧张素转换酶抑制剂(比值比:2.47,95%置信区间:1.71 - 5.42)、静脉注射造影剂(比值比:2.33,95%置信区间:1.64 - 5.39)以及低血压或相关症状(比值比:2.34,95%置信区间:1.67 - 5.43)与严重反应更常相关。我们发现低血压或相关症状、已知的过敏反应病史、β受体阻滞剂/血管紧张素转换酶抑制剂以及静脉注射造影剂是RA的危险因素。为预防具有此危险因素患者的死亡率和发病率,不应避免早期干预措施,如快速重复使用肾上腺素剂量和快速液体复苏。